Do you have glioblastoma? Has your cancer either come back or did not improve after the treatments you received? If so, you may be eligible to participate in this gene therapy research study that wants to learn if a new way to modify your immune cells for use as possible treatment is safe and at what dose.

In this study, we want to use an online survey for people newly diagnosed with metastatic breast cancer to ask questions about physical and emotional health. We hope to use the results of this survey to design a program to help future patients tolerate treatment better.

Have you been diagnosed with Leukemia and are looking for another treatment option? In this study we are looking to see if the study drug DSP-5336 can help control Leukemia or achieve remission.

Have you been diagnosed with advanced unresectable pancreatic cancer. If so, you may be able to take part in a research study looking at the safety and tolerability of olaparib in combination with durvalumab and radiation therapy in patients with pancreatic cancer.

Have you been diagnosed with locally advanced head and neck squamous cell carcinoma? If so, you may be able to participate in a research study to evaluate whether pembrolizumab and olaparib given before and after chemoradiotherapy can improve 1-year progression free survival.

Do you have a newly diagnosed endometrial cancer? if so, you may be eligible to participate in a research study looking at the role the uterine and gut microbiomes play in endometrial cancer development and treatment.

Have you been diagnosed with multiple myeloma that has returned and needed to be treated again? If so, you may be able to take part in a research study looking at the safety of giving a new drug called REGN5458 (Linvoseltamab) to patients with relapsed/refractory multiple myeloma.

In this study, we want to hear from patients with metastatic breast cancer about how their oncologists speak with them about their prognosis. We know these conversations can be challenging, and we want to hear from patients and caregivers about what is helpful or not helpful in those conversations. We also want to hear from patients about a breast cancer-specific tool.

The purpose of this study is to increase the involvement of black breast cancer patients in clinical research trials and connect these patients with resources.

In this study, we want to understand the experiences of Black women in their journey to a diagnosis of endometrial cancer. Learning more about the diagnosis experience will help us to understand what made it easy or difficult to get their diagnosis. This information will help us to develop a tool to improve the endometrial cancer diagnosis experience.